The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, DMK Pharmaceuticals's share price is $0.036.
DMK Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $1.67. Hence, DMK Pharmaceuticals's PS Ratio for today is 0.02.
The historical rank and industry rank for DMK Pharmaceuticals's PS Ratio or its related term are showing as below:
DMKPQ'
s PS Ratio Range Over the Past 10 Years
Min: 0.02 Med: 7.9 Max: 101.59
Current: 0.02
During the past 13 years, DMK Pharmaceuticals's highest PS Ratio was 101.59. The lowest was 0.02. And the median was 7.90.
DMKPQ's PS Ratio is ranked better than 99.6% of 1004
companies
in the Drug Manufacturers industry
Industry Median: 2.16
vs DMKPQ: 0.02
DMK Pharmaceuticals Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of DMK Pharmaceuticals was 133.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -57.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -51.80% per year.
During the past 13 years, DMK Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 105.70% per year. The lowest was -76.10% per year. And the median was -12.50% per year.
Back to Basics: PS Ratio
DMK Pharmaceuticals PS Ratio Historical Data
The historical data trend for DMK Pharmaceuticals's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of DMK Pharmaceuticals's PS Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, DMK Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DMK Pharmaceuticals's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DMK Pharmaceuticals's PS Ratio distribution charts can be found below:
* The bar in red indicates where DMK Pharmaceuticals's PS Ratio falls into.
DMK Pharmaceuticals PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
DMK Pharmaceuticals's Share Price of today is $0.036. DMK Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.67.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
DMK Pharmaceuticals (OTCPK:DMKPQ) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
DMK Pharmaceuticals PS Ratio Related Terms
Thank you for viewing the detailed overview of DMK Pharmaceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
DMK Pharmaceuticals (DMK Pharmaceuticals) Business Description
DMK Pharmaceuticals Corp Formerly Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DMKPQ has been successfully added to your 